Muthana Al Abo

SLFN11 Blocks Stressed Replication Forks Independently of ATR

Junko Murai, Sai-Wen Tang, Elisabetta Leo et al. · Molecular Cell · 2018 · 279 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease

Jeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta et al. · Journal of Hepatology · 2021 · 56 citations · Full text

Medicine, Molecular Biology, Pathology +17

TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors

Muthana Al Abo, Hiroyuki Sasanuma, Xiaojun Liu et al. · Molecular Cancer Therapeutics · 2017 · 45 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey, Sylvain Thierry, Christophe Russo et al. · Clinical Cancer Research · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities

Timothy J. Robinson, Jennifer A. Freedman, Muthana Al Abo et al. · Clinical Cancer Research · 2019 · 42 citations · Full text

Life Sciences, Molecular Biology, Oncology +17